Tirzepatide*
Número de CAS
2023788-19-2
Fórmula Molecular
C225H348N48O68
Peso Molecular
4813.527
Pureza
98%
Solubilidad
DMSO
Apariencia
White powder
Condiciones de almacenamiento
-20℃ ± 5℃
Indicación
Type II diabetes
Descripción del Producto

Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

Documentación del producto

DMF + FDA EIR